A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis (NCT06294925)
EFFECTIVENESS OF ETRASIMOD ON DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN ULCERATIVE COLITIS - EFFECT-UC
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this real world non-interventional study is to learn about the effects of etrasimod as treatment for patients with moderate to severe ulcerative colitis. Patients will be treated according to standard of care and will only be included in the study if etrasimod is the best treatment choice according to the treating physician. Additionally, patients have to be between 18 and 65 years of age and should not have taken etrasimod in the past. All patients will be prescribed etrasimod according to standard of care. Assessments will be conducted according to standard of care with the exception of health questionnaires which will be completed by the patients online on their own device. The study duration is 52 weeks with 28 days of safety follow-up. Patients will visit their treating physician as they would if they were not enrolled in the study. During the study duration, patients will be asked to complete health questionnaires on a regular basis either on their mobile phone, tablet or computer. The effects of etrasimod will be analyzed for each patient comparing to their disease activity prior to the start of etrasimod.
Who can join: Review the eligibility criteria below.
Location: Kelowna Gastroenterology Associates — Kelowna, British Columbia
Age range: 18 Years to 64 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (41 Sites)
Showing the first 25 of 41 sites.
- Kelowna Gastroenterology Associates — Kelowna, British Columbia
- Columbia Medical Building — New Westminster, British Columbia
- Richmond Hospital — Richmond, British Columbia
- Vancouver Coastal Health — Vancouver, British Columbia
- Providence Health Care (PHC) — Vancouver, British Columbia
- London Health Sciences Centre — London, Ontario
- Ottawa Hospital — Ottawa, Ontario
- CHUM — Montreal, Quebec
- Montreal General Hospital — Montreal, Quebec
- Hôpital du Sacré-Cœur de Montréal — Montreal, Quebec
- Gastrofreiburg — Freiburg im Breisgau, Breisgau
- Gastroenterologie OpernstraBe — Kassel, Hesse
- MVZ Gastroenterologie Aachen — Aachen,
- Praxis Heil und Müller — Andernach,
- MVZ für Gastroenterologie am Bayerischen Platz — Berlin,
- Evangelisches Krankenhaus Kalk — Cologne,
- MVZ Dachau — Dachau,
- Interdisziplinares Crohn Colitis Centrum — Frankfurt am Main,
- Facharztpraxis für Gastroenterologie — Grevenbroich,
- Studiengesellschaft BSF UG. — Halle,
- Praxis für Gasteroenterologie — Heidelberg,
- Praxis für Gasteroenterologie Lübeck — Lübeck,
- Klinikum Lüneburg — Lüneburg,
- Internistische Praxengemeinschaft Oldenburg — Oldenburg,
- Magen-Darm-Zentrum Remscheid — Remscheid,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colitis, Ulcerative
- A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis — Oakland, California
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Arcadia, California
- A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Litchfield Park, Arizona
- Determination of the Optimal Treatment Target in Ulcerative Colitis — Ypsilanti, Michigan
- A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis — San Francisco, California
Explore by condition: All Colitis, Ulcerative clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.